A detailed history of Blue Zone Wealth Advisors, LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Blue Zone Wealth Advisors, LLC holds 10,424 shares of NVCT stock, worth $109,035. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,424
Holding current value
$109,035
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 11, 2025

BUY
$5.37 - $10.46 $55,976 - $109,035
10,424 New
10,424 $109,000
Q1 2024

Apr 17, 2024

BUY
$6.69 - $11.0 $96,001 - $157,850
14,350 New
14,350 $117,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $153M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Blue Zone Wealth Advisors, LLC Portfolio

Follow Blue Zone Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Zone Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Zone Wealth Advisors, LLC with notifications on news.